Workflow
湖北美尔雅股份有限公司关于股票交易异常波动的公告

Core Viewpoint - Hubei Meirya Co., Ltd. has experienced significant stock price fluctuations, with a cumulative increase of 62.77% since August 14, 2025, leading to concerns about potential financial and regulatory risks [2][10]. Group 1: Stock Trading Anomalies - The company's stock price deviated significantly, with a cumulative closing price increase of over 12% during three consecutive trading days (August 29, September 1, and September 2, 2025) [2][4]. - The stock has triggered abnormal fluctuation limits three times since August 14, 2025, indicating severe deviation from the Shanghai Composite Index's performance [2][10]. Group 2: Financial Performance - In the first half of 2025, the company reported revenue of 129 million yuan and a net loss of 21.86 million yuan, continuing a trend of losses since 2022 [2][5]. - The company’s revenue for 2024 was 330 million yuan, reflecting a year-on-year decline of 27.42% [5]. Group 3: Audit and Compliance Issues - The auditing firm Zhongshun Zhonghuan issued a qualified opinion on the company's 2024 financial report, and the internal control audit received a negative opinion, indicating significant deficiencies [3][12]. - If the 2025 internal control audit also receives a negative opinion, the company may face regulatory delisting warnings [12][13]. Group 4: Ongoing Investigations - The company and its chairman, Zheng Jiping, are currently under investigation by the China Securities Regulatory Commission, with uncertain outcomes [3][14].